Javascript must be enabled to continue!
Comparative Analysis of PTEN, ER, and PR Expression in Invasive Versus Non-Invasive Breast Carcinoma Across Different Histological Grades in Local Population
View through CrossRef
Objective: The purposes of this study to compare PTEN, ER, and PR expressions between invasive and non-invasive breast carcinoma; and to analyse their expressions according to histological grades.
Method: The study design chosen was the retrospective cohort study and biopsy and surgical specimens from department of pathology MBBS-MC Mirpur, AJK were used. The study consisted of sample of two hundred female patients distributed into two groups, invasive breast carcinoma with one hundred patients and non-invasive breast carcinoma with the other one hundred patients. Histological grading was done according to the Nottingham Grading System guidelines. To measure the stain intensity and the proportion of positively stained cells in relation to PTEN, ER, and PR, immunohistochemistry encircled by antibodies was employed.
Result: The mean H-score of PTEN expression in invasive carcinoma was 4.2 ± 1.7. Majority of patients in this study were staged at T2NOMO while the distribution of tumour stage in non-invasive carcinoma was T1 (n= 6), T2 (n= 11), and T3 (n=39). On average, patients with PFO reported to have had 3 ± 1.4 episodes. For ER, the mean H-score was 5 and tumour invasiveness was found associated with a higher H-score. The mean H-score was found 8±2.1 in invasive tumors and in non-invasive tumors, it was 7. As for PR expression, the mean H-score was 5. Based on histological grading it was noted that well differentiated or Grade 1 tumor sample had the highest scores of the biomarkers where PTEN stood at 6, and ER at 7. The poorly differentiated (Grade 3) tumors expressed the lowest levels of PTEN at 3.2 ±1.8, ER at 4.5±2.2, and PR at 4.0±2.0 for the solution. Spearman’s rho test revealed statistically significant moderate positive correlation between ER and PR (rho = 0. 64, p < 0. 001) while PTEN has statistically significant weak negative correlation with both ER (rho = - 0. 32, p = 0. 02) and PR (rho = - 0.28, p = 0. 03).
Conclusion: There was a significant difference in the PTEN, ER, and PR expression in invasive and non-invasive breast carcinoma as well as in different histological grades. PTEN, ER and PR were higher in non-invasive carcinomas than the invasive carcinomas and in well differentiated than in poorly differentiated carcinomas.
Keywords: PTEN, Estrogen Receptor (ER), Progesterone Receptor (PR), invasive breast carcinoma, non-invasive breast carcinoma, histological grading, immunohistochemistry, biomarkers.
Society of Obstetricians and Gynaecologists of Pakistan
Title: Comparative Analysis of PTEN, ER, and PR Expression in Invasive Versus Non-Invasive Breast Carcinoma Across Different Histological Grades in Local Population
Description:
Objective: The purposes of this study to compare PTEN, ER, and PR expressions between invasive and non-invasive breast carcinoma; and to analyse their expressions according to histological grades.
Method: The study design chosen was the retrospective cohort study and biopsy and surgical specimens from department of pathology MBBS-MC Mirpur, AJK were used.
The study consisted of sample of two hundred female patients distributed into two groups, invasive breast carcinoma with one hundred patients and non-invasive breast carcinoma with the other one hundred patients.
Histological grading was done according to the Nottingham Grading System guidelines.
To measure the stain intensity and the proportion of positively stained cells in relation to PTEN, ER, and PR, immunohistochemistry encircled by antibodies was employed.
Result: The mean H-score of PTEN expression in invasive carcinoma was 4.
2 ± 1.
7.
Majority of patients in this study were staged at T2NOMO while the distribution of tumour stage in non-invasive carcinoma was T1 (n= 6), T2 (n= 11), and T3 (n=39).
On average, patients with PFO reported to have had 3 ± 1.
4 episodes.
For ER, the mean H-score was 5 and tumour invasiveness was found associated with a higher H-score.
The mean H-score was found 8±2.
1 in invasive tumors and in non-invasive tumors, it was 7.
As for PR expression, the mean H-score was 5.
Based on histological grading it was noted that well differentiated or Grade 1 tumor sample had the highest scores of the biomarkers where PTEN stood at 6, and ER at 7.
The poorly differentiated (Grade 3) tumors expressed the lowest levels of PTEN at 3.
2 ±1.
8, ER at 4.
5±2.
2, and PR at 4.
0±2.
0 for the solution.
Spearman’s rho test revealed statistically significant moderate positive correlation between ER and PR (rho = 0.
64, p < 0.
001) while PTEN has statistically significant weak negative correlation with both ER (rho = - 0.
32, p = 0.
02) and PR (rho = - 0.
28, p = 0.
03).
Conclusion: There was a significant difference in the PTEN, ER, and PR expression in invasive and non-invasive breast carcinoma as well as in different histological grades.
PTEN, ER and PR were higher in non-invasive carcinomas than the invasive carcinomas and in well differentiated than in poorly differentiated carcinomas.
Keywords: PTEN, Estrogen Receptor (ER), Progesterone Receptor (PR), invasive breast carcinoma, non-invasive breast carcinoma, histological grading, immunohistochemistry, biomarkers.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract
IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Promoter Methylation and Phosphorylation Status of PTEN in Taiwanese Breast Cancer.
Promoter Methylation and Phosphorylation Status of PTEN in Taiwanese Breast Cancer.
Abstract
Background: The PTEN (phosphatase and tensin homolog deleted on chromosome Ten) gene is a novel candidate of tumor suppressor that plays an important role i...
Induction of PTEN-p53 Crosstalk in Mammary Epithelial Cells: A Novel Mechanism of Breast Cancer Prevention by the Dietary Factor Genistein.
Induction of PTEN-p53 Crosstalk in Mammary Epithelial Cells: A Novel Mechanism of Breast Cancer Prevention by the Dietary Factor Genistein.
Abstract
Consumption of soy foods either at an early age or for lifetime has been associated with reduced risk for developing breast cancer in humans and in animal m...
Abstract 136: PTEN phosphatase inhibits metastasis through negatively affecting Entpd5/IGF1R pathway
Abstract 136: PTEN phosphatase inhibits metastasis through negatively affecting Entpd5/IGF1R pathway
Abstract
Migration of cancer cell is the key event in metastasis. Recent data suggest that PTEN phosphatase activity may be required for inhibiting cell migration; h...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Impact of PTEN, Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression on Prognosis in Different Histological Grades of Breast Carcinoma in a Local Population
Impact of PTEN, Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression on Prognosis in Different Histological Grades of Breast Carcinoma in a Local Population
Objective: The objective of the study was to determine the immunohistochemical staining of PTEN, ER and PR in breast carcinoma and the relationship between these staining and histo...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...

